Daniel Lee

Daniel Lee currently holds the position of VP Enterprise Strategy and Portfolio Analytics at Alnylam Pharmaceuticals. Prior to this, Daniel served as SVP Life Sciences and Growth at Helix where Daniel focused on genomic real world data and evidence studies. Daniel also has a background in enterprise modernization at CVS Health and founded Cadsley Consulting Group. With experience at Pfizer and General Electric, Daniel has a strong foundation in management consulting, business development, and capital markets. Daniel is a seasoned professional with a diverse background in healthcare and engineering.